Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04209374
Other study ID # SYMCOR-1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 3, 2014
Est. completion date March 1, 2018

Study information

Verified date December 2019
Source Dedienne Sante S.A.S.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a single-center retrospective observational cohort study of consecutively operated patients who underwent primary total hip arthroplasty with a SYMBOL CUP DM HA hemispherical dual mobility acetabular implant. The purpose of this study is to estimate the safety and efficacy of that implant at two-year follow-up.


Description:

Description according to PICOS framework:

Patients:

- Adult men and women requiring a primary total hip arthroplasty

Intervention:

- Primary THA with SYMBOL CUP DM HA hemispherical dual mobility acetabular implant.

Comparator: None

Outcomes:

- Safety 1: Implant survival over 2-year follow-up.

- Safety 2: All adverse events, with focus on implant dislocation, infections, revision surgery

- Efficacy 1: Harris Hip Score (HHS) at baseline and 1-year follow-up.

- Efficacy 2: Modified HHS consisting of pain + functional subscores at baseline, 1-year and 2-year follow-ups.

- Efficacy 2: Devane score at baseline, 1-year and 2-year follow-ups.

- Efficacy 3: Charnley classification at baseline, 1-year and 2-year follow-ups.

Study design:

- single-center retrospective observational cohort study of consecutively operated patients who underwent primary total hip arthroplasty 2 years prior to study start.

- Prospective 2-year follow-up letter and phone questionnaire.


Recruitment information / eligibility

Status Completed
Enrollment 59
Est. completion date March 1, 2018
Est. primary completion date December 17, 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- All patients with total hip implant using hemispheric dual-mobility SYMBOL CUP DM HA

- Operation performed by the primary investigator

- Delay between index operation and March 1 2018 has reached 2 years

Exclusion Criteria:

- patient refusal to participate in the study

- minors (age < 18 years)

- patients under guardianship

Study Design


Related Conditions & MeSH terms


Intervention

Device:
THA with SYMBOL CUP DM HA


Locations

Country Name City State
France Lyon Ortho Clinic - Clinique de la Sauvegarde Lyon

Sponsors (1)

Lead Sponsor Collaborator
Dedienne Sante S.A.S.

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Implant survival: Ratio of the number of participants alive with the complete index hip prosthesis in position at 2-year follow-up, over their initial numberprosthesis in position at 2-year follow-up, over their initial number. This is the ratio of the number of participants who are alive with the complete index hip prosthesis in position at a given follow-up time (numerator) over the initial number of those participants from the date they received the index hip prosthesis (denominator). The cumulative ratio is recalculated at each event using the Kaplan-Meier method from the date of each participant index operation through the date of each participant's death or prosthetic removal surgery or loss-to-follow-up or last assessment alive with the hip prosthesis in place. The longest duration between the index operation and the final assessment is 2 years. 2 years as of index operation
Secondary Number of patients with one or several post-operative adverse events and count of each Serious adverse event and aggregate count of adverse events All serious post-operative adverse events are taken into account including implant dislocation, infections, revision surgery 2 years as of index operation
Secondary Harris Hip Score (HHS) at baseline and 1-year follow-up The score is measured at each assessment in each patient. The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments 1 year as of index operation
Secondary The modified Harris Hip Score (modified HHS) at baseline, 1-year and 2-year follow-up The modified Harris Hip Score (modified HHS) is the sum of pain subscore and functional subscore of the Harris Hip Score. The score is measured at each assessment in each patient. The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments 2 years as of index operation
Secondary Devane classification at baseline, 1-year and 2-year follow-up. The class is measured at each assessment in each patient. The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments 2 years as of index operation
Secondary Charnley classification at baseline, 1-year and 2-year follow-up. The class is measured at each assessment in each patient. The mean and confidence interval of the score is measured at each assessment as well as for the within-patient difference between assessments 2 years as of index operation
See also
  Status Clinical Trial Phase
Recruiting NCT03968939 - Total Joint Arthroplasty and Sleep Phase 4
Terminated NCT04036071 - Clinical Observation Study of the Hydroxylapatite-coated SLPLUS™MIA Hip Shaft
Completed NCT04209426 - Retrospective Observational Cohort Study of SYMBOL CUP DM 2
Enrolling by invitation NCT05313321 - Survival of the Insignia Stem in Total Hip Arthroplasty
Terminated NCT04121585 - Clinical Observation Study of the Hydroxylapatite-coated SL-PLUS™ Hip Shaft
Completed NCT03690037 - Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty Phase 4
Completed NCT04122157 - Prospective Single-center Long-term Observation of the SL-PLUS® MIA Stem
Completed NCT04085640 - Obturator Nerve Block in Total Hip Arthrosplasty N/A
Recruiting NCT04319952 - OPS™ With Direct Anterior Approach (DAA)
Completed NCT05072704 - Opioid Free Anesthesia in Total Hip Arthroplasty Phase 3
Completed NCT03973320 - Outcomes After Hypotensive Neuraxial Anesthesia in Total Hip Arthroplasty
Recruiting NCT01495546 - Total Hip Arthroplasty (THA): Early Load Versus Load Late N/A
Terminated NCT02933671 - Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty Phase 4
Completed NCT03956381 - Accuracy of OPS™ Femoral Neck Resection Study